A prospective study of using a new method of minimally invasive cervical esophagogastrostomy to reduce the incidence of anastomotic leakage

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036116

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophagus cancer

Interventions

experimental group:new method of minimally invasive cervical esophagogastrostomy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Histologically proven esophageal cancer; 3. Resectable cT1-T3/N0-N1 Disease; 4. ECOG score 0-1; 5. Acceptable pulmonary and cardiac function; 6. Acceptable hepatic, renal and bone marrow function; 7. Patient was not pregnant.

Exclusion criteria

Exclusion criteria: 1. Past history of malignancy; 2. Patients with any other serious underlying medical condition that would impair the ability of the patient to receive or comply with protocol treatment; 3. Salvage surgery after definitive chemoradiotherapy; 4. Unreliable for follow up.

Design outcomes

Primary

Measure	Time frame
Incidence of anastomotic leakage;	—

Secondary

Measure	Time frame
Quality of life;	—

Countries

China

Contacts

Public ContactYihua Sun

Shanghai Cancer Center Fudan University

sun_yihua76@hotmail.com+86 18017317074

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026